Wednesday
14.00 - 14.30 CET
Is basal-bolus still the go-to option for the uncontrolled T2D basal insulin patient?
Industry Meet the Expert Session
Gurpreet Anand (Switzerland)
Effectiveness of basal-bolus in T2D
Adie Viljoen (UK) & Gurpreet Anand (Switzerland)
Alternatives to basal-bolus in T2D: basal insulin + GLP-1 RA synergies
All faculty
Q&A
Hosted by:
Novo Nordisk A/S